Vaccination Protocol

HOME
About Us
Consultation
Internet Radio Show
Articles Of Interest
Whole Dog News Blog
Book Store
Food Pantry
Health Care Products
Natural Grooming Products
Beds
Accessories & Clothing
Toys
Income Opportunities
Links
Our Boston Terriers

The Whole Dog Store

Vaccination Protocol

If You Should Choose To Vaccinate

Should you, after research, decide you want to continue to vaccinate your new puppy or dog, Please be aware of the following data and research:


Some Facts you should be aware of:
Dogs' and cats' immune systems are not fully mature until they are about 6 months old. If duration of antibodies studies are correct, a modified live virus (MLV) vaccine is given after 6 months of age, produces immunity, which is good for the life of the pet (i.e., canine distemper, parvo, feline distemper). If another MLV vaccine is given a year later, the antibodies from the first vaccine actually neutralize the antigens of the second vaccine and there is little or no effect. The titer is not 'boosted' nor are more memory cells induced.

Not only are annual boosters for parvo and distemper unnecessary, they subject the pet to potential risks of allergic reactions and immune-mediated hemolytic anemia. There is no scientific documentation to back up label claims for annual administration of MLV vaccines. Puppies receive antibodies through their mother's milk. This natural protection can last 8-14 weeks. Puppies and kittens should NOT be vaccinated at LESS than 8 weeks. Maternal immunity will neutralize the vaccine and little protection (0-38%) will be produced. Vaccination at 6 weeks will, however, delay the timing of the first highly effective vaccine. Vaccinations given 2 weeks apart suppress rather than stimulate the immune system. A series of vaccinations is given starting at 8 weeks and given 3-4 weeks apart up to 16 weeks of age. Another vaccination given sometime after 6 months of age (usually at 1 year 4 months) will provide lifetime immunity.

Articles On Vaccinations Pros & Cons
Vaccines - Are They Safe for Your Dog?
Health Hazzard Of Routine Vaccinations>/a>
To Vaccinate Or Not to Vaccinate
Truth About Vaccines

CHANGING VACCINE PROTOCOLS
Dr Jean Dodds

The challenge to produce effective and safe vaccines for the prevalent infectious diseases of humans and animals has become increasingly difficult. In veterinary medicine, evidence implicating vaccines in triggering immune-mediated and other chronic disorders (vaccinosis) is compelling. While some of these problems have been traced to contaminated or poorly attenuated batches of vaccine that revert to virulence, others apparently reflect the host's genetic predisposition to react adversely upon receiving the single (monovalent) or multiple antigen "combo" (polyvalent) products given routinely to animals. Animals of certain susceptible breeds or families appear to be at increased risk for severe and lingering adverse reactions to vaccines.

The onset of adverse reactions to conventional vaccinations (or other inciting drugs, chemicals, or infectious agents) can be an immediate hypersensitivity or anaphylactic reaction, or can occur acutely (24-48 hours afterwards), or later on (10-45 days) in a delayed type immune response often caused by immune-complex formation. Typical signs of adverse immune reactions include fever, stiffness, sore joints and abdominal tenderness, susceptibility to infections, central and peripheral nervous system disorders or inflammation, collapse with autoagglutinated red blood cells and jaundice, or generalized pinpoint hemorrhages or bruises. Liver enzymes may be markedly elevated, and liver or kidney failure may accompany bone marrow suppression. Furthermore, recent vaccination of genetically susceptible breeds has been associated with transient seizures in puppies and adult dogs, as well as a variety of autoimmune diseases including those affecting the blood, endocrine organs, joints, skin and mucosa, central nervous system, eyes, muscles, liver, kidneys, and bowel. It is postulated that an underlying genetic predisposition to these conditions places other littermates and close relatives at increased risk. Vaccination of pet and research dogs with polyvalent vaccines containing rabies virus or rabies vaccine alone was recently shown to induce production of antithyroglobulin autoantibodies, a provocative and important finding with implications for the subsequent development of hypothyroidism (Scott-Moncrieff et al, 2002).

Vaccination also can overwhelm the immunocompromised or even healthy host that is repeatedly challenged with other environmental stimuli and is genetically predisposed to react adversely upon viral exposure. The recently weaned young puppy or kitten entering a new environment is at greater risk here, as its relatively immature immune system can be temporarily or more permanently harmed. Consequences in later life may be the increased susceptibility to chronic debilitating diseases. As combination vaccines contain antigens other than those of the clinically important infectious disease agents, some may be unnecessary; and their use may increase the risk of adverse reactions. With the exception of a recently introduced mutivalent Leptospira spp. vaccine, the other leptospirosis vaccines afford little protection against the clinically important fields strains of leptospirosis, and the antibodies they elicit typically last only a few months. Other vaccines, such as for Lyme disease, may not be needed, because the disease is limited to certain geographical areas. Annual revaccination for rabies is required by some states even though there are USDA licensed rabies vaccine with a 3-year duration. Thus, the overall risk-benefit ratio of using certain vaccines or multiple antigen vaccines given simultaneously and repeatedly should be reexamined. It must be recognized, however, that we have the luxury of asking such questions today only because the risk of disease has been effectively reduced by the widespread use of vaccination programs.

Given this troublesome situation, what are the experts saying about these issues? In 1995, a landmark review commentary focused the attention of the veterinary profession on the advisability of current vaccine practices. Are we overvaccinating companion animals, and if so, what is the appropriate periodicity of booster vaccines ? Discussion of this provocative topic has generally lead to other questions about the duration of immunity conferred by the currently licensed vaccine components. In response to questions posed in the first part of this article, veterinary vaccinologists have recommended new protocols for dogs and cats. These include: 1) giving the puppy or kitten vaccine series followed by a booster at one year of age; 2) administering further boosters in a combination vaccine every three years or as split components alternating every other year until; 3) the pet reaches geriatric age, at which time booster vaccination is likely to be unnecessary and may be unadvisable for those with aging or immunologic disorders. In the intervening years between booster vaccinations, and in the case of geriatric pets, circulating humoral immunity can be evaluated by measuring serum vaccine antibody titers as an indication of the presence of immune memory. Titers do not distinguish between immunity generated by vaccination and/or exposure to the disease, although the magnitude of immunity produced just by vaccination is usually lower (see Tables).

Except where vaccination is required by law, all animals, but especially those dogs or close relatives that previously experienced an adverse reaction to vaccination can have serum antibody titers measured annually instead of revaccination. If adequate titers are found, the animal should not need revaccination until some future date. Rechecking antibody titers can be performed annually, thereafter, or can be offered as an alternative to pet owners who prefer not to follow the conventional practice of annual boosters. Reliable serologic vaccine titering is available from several university and commercial laboratories and the cost is reasonable (Twark and Dodds, 2000; Lappin et al, 2002; Paul et al, 2003; Moore and Glickman, 2004).

Relatively little has been published about the duration of immunity following vaccination, although new data are beginning to appear for both dogs and cats.

Our recent study (Twark and Dodds, 2000), evaluated 1441 dogs for CPV antibody titer and 1379 dogs for CDV antibody titer. Of these, 95.1 % were judged to have adequate CPV titers, and nearly all (97.6 %) had adequate CDV titers. Vaccine histories were available for 444 dogs (CPV) and 433 dogs (CDV). Only 43 dogs had been vaccinated within the previous year, with the majority of dogs (268 or 60%) having received a booster vaccination 1-2 years beforehand. On the basis of our data, we concluded that annual revaccination is unnecessary. Similar findings and conclusions have been published recently for dogs in New Zealand (Kyle et al, 2002), and cats (Scott and Geissinger, 1999; Lappin et al, 2002). Comprehensive studies of the duration of serologic response to five viral vaccine antigens in dogs and three viral vaccine antigens in cats were recently published by researchers at Pfizer Animal Health ( Mouzin et al, 2004). When an adequate immune memory has already been established, there is little reason to introduce unnecessary antigen, adjuvant, and preservatives by administering booster vaccines. By titering annually, one can assess whether a given animal's humoral immune response has fallen below levels of adequate immune memory. In that event, an appropriate vaccine booster can be administered.

Titer Test Forms That You Can Print out http://www.itsfortheanimals.com/HEMOPET.htm

Titers

What is titer testing? A titer test (pronounced TIGHT er) is a laboratory test measuring the existence and level of antibodies in blood. Antibodies are produced when an antigen (like a virus or bacteria) provokes an immune response. This response can come from natural exposure or from vaccination. (Note: titering is also called serum vaccine antibody titering and serologic vaccine titering.)

If you are one of many, who worry about vaccine safety or over vaccinating your dog, this affordable alternative can be asked for from your veterinarian.

Please note that no titer reading at all doesn't mean the dog is not protected. Titers will only read the antibodies in the blood. There is also "Cellular Immunity" protecting a body - the "cell-mediated immune response". This can not be measured with a blood test. This is when the "T-cells" kick in and act as "killer" cells. This not only works for viruses but can also do the same against cancer cells. Another reason it's so important to keep the immune system healthy and working properly!! And another reason for so much cancer in our animals - over-vaccinating! !! We are annihilating their immune response and will they no longer work.

Here is a Video on cell mediated immune response HERE

ONLY a vet may submit blood for the titers. Antech Lab, NYC 1-800 872 -1001 (who does our Combo Titers), and also through Hemopet who will also do the Rabies titer . They titer for Distemper, Parvo, Corona at a total cost of $75 PER DOG. Lepto titers are not diagnostic yet (in other words they can titer for it, but haven't developed a proven Titer for Lepto yet), so if you have Lepto in the area, you should get the vaccine if your vet suggests. Some small dogs react to Lepto vaccines.....so many recommend not to vaccinate unless you have to. Antech Lab, NYC 1-800 872 -1001

Hemopet Office: (Wed/Thurs)
Phone: 714-891-2022 --Pacific Time
Fax: 714-891-2123
11330 Markon Dr
Garden Grove, CA 92841 USA

(PLEASE DO NOT EMAIL The Whole Dog site owner Regarding Hemopet, Titers, or Vaccination Protocols!!!!
Use the email address provided below

To Contact Dr. Jean Dodds:
EMAIL:Hemopet@hotmail.com

References
Dodds WJ. More bumps on the vaccine road. Adv Vet Med 41:715-732, 1999.
Dodds WJ. Vaccination protocols for dogs predisposed to vaccine reactions. J Am An Hosp Assoc 38: 1-4, 2001.
Hogenesch H, Azcona-Olivera J, Scott-Moncreiff C, et al. Vaccine-induced autoimmunity in the dog. Adv Vet Med 41: 733-744, 1999.
Hustead DR, Carpenter T, Sawyer DC, et al. Vaccination issues of concern to practitioners. J Am Vet Med Assoc 214: 1000-1002, 1999.
Kyle AHM, Squires RA, Davies PR. Serologic status and response to vaccination against canine distemper (CDV) and canine parvovirus (CPV) of dogs vaccinated at different intervals. J Sm An Pract, June 2002.
Lappin MR, Andrews J, Simpson D, et al. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. J Am Vet Med Assoc 220: 38-42, 2002.
McGaw DL, Thompson M, Tate, D, et al. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination. J Am Vet Med Assoc 213: 72-75, 1998.
Moore GE, Glickman LT. A perspective on vaccine guidelines and titer tests for dogs. J Am Vet Med Assoc 224: 200-203. 2004.
Mouzin DE, Lorenzen M J, Haworth, et al. Duration of serologic response to five viral antigens in dogs. J Am Vet Med Assoc 224: 55-60, 2004.
Mouzin DE, Lorenzen M J, Haworth, et al. Duration of serologic response to three viral antigens in cats. J Am Vet Med Assoc 224: 61-66, 2004.
Paul MA. Credibility in the face of controversy. Am An Hosp Assoc Trends Magazine XIV(2):19-21, 1998.
Paul MA (chair) et al. Report of the AAHA Canine Vaccine Task Force: 2003 canine vaccine guidelines, recommendations, and supporting literature. AAHA, April 2003, 28 pp.
Schultz RD. Current and future canine and feline vaccination programs. Vet Med 93:233-254, 1998.
Schultz RD, Ford RB, Olsen J, Scott F. Titer testing and vaccination: a new look at traditional practices. Vet Med, 97: 1-13, 2002 (insert).
Scott FW, Geissinger CM. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 60: 652-658, 1999.
Scott-Moncrieff JC, Azcona-Olivera J, Glickman NW, et al. Evaluation of antithyroglobulin antibodies after routine vaccination in pet and research dogs. J Am Vet Med Assoc 221: 515-521, 2002.
Smith CA. Are we vaccinating too much? J Am Vet Med Assoc 207:421-425, 1995.
Tizard I, Ni Y. Use of serologic testing to assess immune status of companion animals. J Am Vet Med Assoc 213: 54-60, 1998.
Twark L, Dodds WJ. Clinical application of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs. J Am Vet Med Assoc 217:1021-1024, 2000.
_______________________________________

* Veterinary Medicine, February, 2002.
Table 3. Titer Testing and Vaccination *
While difficult to prove, risks associated with overvaccination are an increasing concern among veterinarians. These experts say antibody titer testing may prove to be a valuable tool in determining your patients' vaccination needs.
_____________________________________________________

* Veterinary Medicine, February, 2002.
Table 4. Vaccine Titer Testing *
Research shows that once an animal's titer stabilizes,it is likely to remain constant for many years.
_____________________________________________

Disclaimer
The information provided herein should be viewed as opinion based on research into the medical implications and contraindications of current veterinary treatments and procedures and should not be used for diagnosing or treating a health condition, symptoms or a disease in your pet. It is not a substitute for professional veterinary care or consultations with qualified veterninary naturopaths or true holistic veterinarians whose professional advice you trust. .